VIEMED HEALTHCARE, INC. VMD revenue by segment, product and geography
In its fiscal year ending 2025-12-31, VIEMED HEALTHCARE, INC. reported revenue across 2 products and services; the largest, Equipment Sales, was $50.3M, 66.9% of the filed sum (+62.7% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Equipment Sales$50.3M66.9%+62.7% yoy
- Service$24.9M33.1%+23.6% yoy
Members sum to $75.1M against $270M consolidated (residual $195M) - eliminations or corporate lines the filer did not tag on this axis.
- Equipment Sales$17.5M73.3%+132.6% yoy
- Service$6.37M26.7%-1.9% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.